Subscribe now to view details for this work, and gain access to over 18 million auction results. Purchase One-Day Pass ...

Biogen enhances its portfolio and margins amidst market challenges and competition. Click here to find out why BIIB stock is ...

The big biotech signed a 15-year lease for approximately 580,000-square-feet of space in “Kendall Commons,” a development ...

With its move to MIT’s Volpe Center in Kendall Square, the drugmaker is consolidating its local footprint from three ...

As part of a bid to consolidate its footprint in Massachusetts, Biogen is foregoing its old home base to put down new roots ...

Cambridge-based biotechnology company Biogen Inc. announced Monday that it will move its global headquarters to a new ...

Biogen signs lease for Kendall Common as part of multi-year real estate optimization plan to modernize its facilities and consolidate its ...

Biogen signs lease for Kendall Common as part of multi-year real estate optimization plan to modernize its facilities and consolidate its Massachusetts real estate footprint New building will be ...

The lease is one of the most significant life sciences real estate transactions in Greater Boston since the industry slowdown led to a major fall-off in demand more than two years ago. Biogen Inc ...

The biotech company plans to move into the new development in 2028, consolidating other leased and owned spaces in the ...

Biogen Inc. closed 41.04% below its 52-week high of $238.00, which the company achieved on July 12th.